To provide causal evidence of the role of RUNX3 in CCRCC development and progression, we first determined RUNX3 expression in six human CCRCC tissues and two derived cell lines in mRNA and protein levels, compared with the matched adjacent noncancerous tissues and the human normal kidney proximal tubular cell lines. Here, RUNX3 is linked to nonpapillary renal cell carcinoma.